Technical Analysis for MYNZ - Mainz Biomed B.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.72 | -8.19% | -0.06 |
MYNZ closed down 8.19 percent on Wednesday, May 8, 2024, on 1.7 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | -8.19% | |
New 52 Week Low | Weakness | -8.19% | |
Outside Day | Range Expansion | -8.19% | |
Wide Bands | Range Expansion | -8.19% | |
Lower Bollinger Band Touch | Weakness | -8.19% |
Alert | Time |
---|---|
Down 10% | about 12 hours ago |
Possible Inside Day | about 13 hours ago |
60 Minute Opening Range Breakdown | about 14 hours ago |
10 DMA Resistance | about 16 hours ago |
2x Volume Pace | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Colorectal Cancer Pancreatic Cancer Medical Test Diagnostic Tests Molecular Diagnostics Cancer Screening Innogenetics
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Colorectal Cancer Pancreatic Cancer Medical Test Diagnostic Tests Molecular Diagnostics Cancer Screening Innogenetics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.0 |
52 Week Low | 0.7 |
Average Volume | 110,865 |
200-Day Moving Average | 1.82 |
50-Day Moving Average | 0.95 |
20-Day Moving Average | 0.86 |
10-Day Moving Average | 0.79 |
Average True Range | 0.09 |
RSI (14) | 33.77 |
ADX | 22.36 |
+DI | 11.91 |
-DI | 20.68 |
Chandelier Exit (Long, 3 ATRs) | 0.87 |
Chandelier Exit (Short, 3 ATRs) | 0.96 |
Upper Bollinger Bands | 1.03 |
Lower Bollinger Band | 0.69 |
Percent B (%b) | 0.09 |
BandWidth | 39.62 |
MACD Line | -0.07 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.0117 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.86 | ||||
Resistance 3 (R3) | 0.87 | 0.83 | 0.84 | ||
Resistance 2 (R2) | 0.83 | 0.80 | 0.83 | 0.83 | |
Resistance 1 (R1) | 0.78 | 0.78 | 0.76 | 0.77 | 0.82 |
Pivot Point | 0.74 | 0.74 | 0.73 | 0.74 | 0.74 |
Support 1 (S1) | 0.68 | 0.71 | 0.67 | 0.67 | 0.62 |
Support 2 (S2) | 0.65 | 0.68 | 0.64 | 0.61 | |
Support 3 (S3) | 0.59 | 0.65 | 0.60 | ||
Support 4 (S4) | 0.58 |